Strategic Intellectual Property Insight Platform

See the following -

I.B.M. Using Bits of Watson for Drug Research

Steve Lohr | The New York Times | December 8, 2011

The ingredients that went into the Watson arsenal are steadily finding their way into I.B.M. products. For example, WellPoint, the big health insurer, is trying out a system that uses Watson-style software to reduce redundant medical tests.

Read More »